Clinical trial
Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors
NCT00448786 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00448786 |
|---|---|
| Title | Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors |
| Official title | An Open-Label, Randomized, Phase 1b Study Evaluating the Effect of Different Doses of AMG 706 on the Gallbladder in Subjects With Advanced Solid Tumors |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | AMG 706 |
| Enrollment | 49 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Mar 19, 2007 |
| Last update posted | Jan 21, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: